What stage does Oxford Investment Consultants LLP invest at?

Oxford Investment Consultants LLP invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.

Where is Oxford Investment Consultants LLP located?

Oxford Investment Consultants LLP is headquartered in Oxford, GB.

Who does Oxford Investment Consultants LLP co-invest with?

Oxford Investment Consultants LLP most often shares deals with Oxford Science Enterprises, Creative Destruction Lab (CDL), Longwall Venture Partners LLP, among 4 tracked co-investors.

Oxford Investment Consultants LLP

Venture capital

Oxford · Seed–Late Stage · 9 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

The firm invests in university deep-science spinouts, believing that deep integration within university spinout ecosystems compounds knowledge, access and long-term returns. Through the tax-efficient EIS-structured OTIF, it offers sophisticated investors access to high-potential spinouts from Oxford University and other UK research institutions, aiming for long-term capital growth, portfolio diversification and enhanced risk-adjusted returns. Investments span early-stage opportunities from Seed and follow-on through to exit, as well as select de-risked growth opportunities. Beyond capital, the team supports portfolio companies as board representatives and strategic partners to maximise value creation.

Invests inAdvanced Manufacturing AI & Machine Learning Biotech Cleantech Consumer Deep Tech EdTech Energy Enterprise Software Hardware Healthtech IoT Medical Devices New Materials Quantum Computing SaaS Oxford United Kingdom

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Late Stage

Oxford, GB

Instruments

Equity

Founded

2015

Tracked investments

Team · 9 people

from the firm's website & public directories

Charalambos Antoniades· Professor

Founder and CSO of Caristo Diagnostics, an expert on the role of inflammation and fat in the body who spent over a decade developing methods to visualise and quantify cardiac inflammation from medical images. His validation study was published in the Lancet in 2018.

George Robinson· Founding Partner· Greater Oxford Areain

Founder of OTIF Ventures and co-founder/partner of Sloane Robinson LLP, a global listed-equities investment manager focused on Asian and emerging markets. Active early-stage tech and biotech investor with a focus on Oxford spinouts, founding partner of Technikos, and honorary fellow of Keble College, Oxford.

Peter Leek· Founder· Oxfordin

Leads the UK's superconducting quantum computing development at the QCS Hub and is principal investigator at the Leek Lab in Oxford, where he and his team developed OQC's core Coaxmon IP.

Christopher Hall· Partner· United Kingdomin

Former partner at law firm Latham & Watkins (until 2017) with a career spanning telecommunications, technology, finance and law across multiple continents. Has served on boards of technology, healthcare, IT, financial, education and HR companies.

c•••@oxfordinvestmentconsultants.comreveal

James Mallinson· Partner· Greater Oxford Areain

Joined OTIF Ventures in 2018 after 15 years managing the University of Oxford's technology spinout portfolio as Director of Oxford Spinout Equity Management. Brings over 25 years of venture experience across technology and life science spinouts including NaturalMotion, Oxitec, Oxford Immunotec, Immunocore and Adaptimmune.

j•••@oxfordinvestmentconsultants.comreveal

Tania Wilson· Principal and CFO· Oxford, England, United Kingdomin

Joined OTIF Ventures in 2019 with over 16 years in finance focused on valuation and transactions in software and computer services. Previously a Director at PwC leading South-East valuations; a Chartered Management Accountant who serves on three company boards and writes for TechMarketView.

William Middleton· Principal· London, England, United Kingdomin

Has 20 years of investment management experience, previously at Sloane Robinson. Portfolio manager of Technikos LLP, a biomedical engineering fund, and holds board roles at Oxford spinouts including Caristo Diagnostics and Oxford Brain Diagnostics.

w•••@oxfordinvestmentconsultants.comreveal

Alexander Chamberlain· Senior Associate· London, England, United Kingdomin

Joined OTIF Ventures in 2019 with over seven years in venture capital, focusing on deeptech and cleantech investments. Board Director of Nitech Solution and Board Observer of Oxford Space Systems; previously at New Street Research and Seraphim Capital.

a•••@oxfordinvestmentconsultants.comreveal

Hector Edwards· Associate· United Kingdomin

Joined OTIF Ventures in 2023 focusing on life science investments. A former NHS medical doctor who previously advised family offices and non-profits on impact investment at New Philanthropy Capital; serves as Board Director at Panda Surgical and Board Observer at SpyBiotech and Biofidelity.

h•••@oxfordinvestmentconsultants.comreveal

What they invest in

from 1 of 3 portfolio companies

Deep Tech ×1Enterprise Software ×1Hardware ×1Quantum Computing ×1

HQs:United Kingdom×2

Investments · 3 tracked

founders shown can be your intro path

Caristo Diagnosticscaristo.com in 𝕏

Co-investorsCreative Destruction Lab (CDL)Longwall Venture Partners LLP Oxford Science Enterprises

Otifotif.vc in

OTIF is a UK-based venture capital firm that invests in deep-science university spinouts, primarily from Oxford University and other UK research institutions, across life sciences, deep tech, and physical sciences.

Oxford, GB

Oxford Quantum Circuitsoxfordquantumcircuits.com in 𝕏

Oxford Quantum Circuits (OQC) develops and operates superconducting quantum computers for commercial and strategic applications, offering Quantum-Compute-as-a-Service and integrating quantum systems directly into commercial data centres.

Deep TechEnterprise SoftwareHardwareQuantum ComputingOxford, GB

Peter Leek(Founder & CSO)inGerald Mullally(CEO)Simon Phillips(CTO)Nikki Cooper(CLO)Robert Coutts(CFO)

BoardJack Boyer(Chairman of the Board)

Co-investorsOxford Science Enterprises British Business Bank Oxford UTEC

Principals & officers · per Companies House

what is this? ⓘ

Christopher Delafield Hall

LLP designated member · since 2017

Ross Kevin Hyett

LLP designated member · since 2014

James Hugh Charteris Mallinson

LLP designated member · since 2018

George Edward Silvanus Robinson

LLP designated member · since 2014

Ownership & control

George Edward Silvanus Robinson — significant influence or control limited liability partnership

Ross Kevin Hyett — significant influence or control limited liability partnership

Frequently asked questions

What stage does Oxford Investment Consultants LLP invest at?: Oxford Investment Consultants LLP invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does Oxford Investment Consultants LLP focus on?: Oxford Investment Consultants LLP focuses on Advanced Manufacturing, AI & Machine Learning, Biotech, Cleantech, Consumer, Deep Tech, EdTech, Energy, Enterprise Software, Hardware, Healthtech, IoT, Medical Devices, New Materials, Quantum Computing, SaaS.
Where is Oxford Investment Consultants LLP located?: Oxford Investment Consultants LLP is headquartered in Oxford, GB.
Who does Oxford Investment Consultants LLP co-invest with?: Oxford Investment Consultants LLP most often shares deals with Oxford Science Enterprises, Creative Destruction Lab (CDL), Longwall Venture Partners LLP, among 4 tracked co-investors.

Images

Similar investors

Khosla Ventures

Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.

$5K – $50M

Alibaba Entrepreneurs Fund

The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.

$1.2M – $150M

BDC Fund Investments (Fund-of-Funds)

BDC Fund Investments is the fund-of-funds arm of BDC Capital that acts as a limited partner, backing emerging and established fund managers who invest in technology-focused Canadian companies.

Cowin Capital Group

Cowin Capital Group is a Chinese investment management firm with extensive experience investing in and exiting technology, healthcare, and industrial companies, many of which have gone public on Chinese and Hong Kong exchanges.

$1.4M – $50M

Everywhere Ventures

Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.

$250K